“My goal was just being able to contribute towards the advancement of research for a cure in whatever capacity,” said Caldwell, a San Francisco-based operations manager who was diagnosed with HIV eight years ago.
Regenerative medicine makes use of human cells or tissues that are engineered in the lab or taken from donors. It is the first time such trials have won state sanction in the United States, with the Food and Drug Administration (FDA) hoping transformative treatments might later emerge.
The first generation of FDA-approved trials at clinics across the United States are examining the impact of stem cell, CAR-T cell and antibody therapies on patients with a host of conditions, ranging from HIV to brain cancer and lymphoma. “I knew